Pseudomonas aeruginosa strains from the chronically infected cystic fibrosis lung display increased invasiveness of A549 epithelial cells over time

2012 ◽  
Vol 53 (1) ◽  
pp. 37-43 ◽  
Author(s):  
Christopher J. Harmer ◽  
James A. Triccas ◽  
Honghua Hu ◽  
Barbara Rose ◽  
Peter Bye ◽  
...  
2006 ◽  
Vol 74 (5) ◽  
pp. 2975-2984 ◽  
Author(s):  
Mónica A. Delgado ◽  
Jens F. Poschet ◽  
Vojo Deretic

ABSTRACT Pseudomonas aeruginosa is a critical colonizer of the respiratory tract in cystic fibrosis. The chronic infections with this microorganism contribute to excessive inflammation and progressive lung damage in cystic fibrosis patients. The full repertoire of Pseudomonas products that promote inflammation in the cystic fibrosis lung is not known. Here we show that P. aeruginosa DNA released from the bacterium, but not human DNA from epithelial cells or Escherichia coli DNA, displays proinflammatory properties and induces human respiratory epithelial cells to secrete interleukin-8 (IL-8), a key chemokine causing excessive neutrophil infiltration in the cystic fibrosis lung. IL-8 secretion was not due to an increase in NF-κB- or activator protein-1-dependent IL-8 promoter transcription, but instead depended on p38 and Erk mitogen-activated protein kinases. No secretion of IL-8 was observed using conventional Toll-like receptor 9 ligands (CpG oligonucleotides), although it could be demonstrated that parts of the Toll-like receptor 9-signaling pathway were functional, since class B and C CpG oligonucleotide ligands stimulated production of RANTES chemokine. The IL-8 secretion in response to P. aeruginosa DNA was decreased by treatments that inhibit acidification of intracellular organelles, using chloroquine, a pH-neutralizing compound, or bafilomycin A1, an inhibitor of vacuolar H+-ATPase. These data indicate that DNA released from P. aeruginosa during chronic infections may significantly contribute to the proinflammatory processes in cystic fibrosis. Our findings also show that treatments with drugs diminishing organellar acidification may reduce the inflammatory response in cystic fibrosis.


2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Mathew R. Crull ◽  
Kathleen J. Ramos ◽  
Ellen Caldwell ◽  
Nicole Mayer-Hamblett ◽  
Moira L. Aitken ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Eva Vandeplassche ◽  
Andrea Sass ◽  
Astrid Lemarcq ◽  
Ajai A. Dandekar ◽  
Tom Coenye ◽  
...  

PLoS ONE ◽  
2009 ◽  
Vol 4 (12) ◽  
pp. e8439 ◽  
Author(s):  
Cristina Cigana ◽  
Laura Curcurù ◽  
Maria Rosaria Leone ◽  
Teresa Ieranò ◽  
Nicola Ivan Lorè ◽  
...  

2015 ◽  
Vol 197 (14) ◽  
pp. 2250-2251 ◽  
Author(s):  
Patricia M. Barnabie ◽  
Marvin Whiteley

Communication is an important factor for bacterial survival, growth, and persistence. Much work has examined both inter- and intraspecies interactions and their effects on virulence. Now, researchers have begun to explore the ways in which host-modulated factors can impact bacterial interactions and subsequently affect patient outcomes. In this issue, two papers discuss how the host environment alters interactions between the pathogensPseudomonas aeruginosaandStaphylococcus aureus, largely in the context of cystic fibrosis.


Sign in / Sign up

Export Citation Format

Share Document